{
    "clinical_study": {
        "@rank": "13127", 
        "arm_group": {
            "arm_group_label": "Ulthera\u00ae treatment", 
            "arm_group_type": "Experimental", 
            "description": "All enrolled subjects will receive one full face and neck Ulthera\u00ae treatment."
        }, 
        "brief_summary": {
            "textblock": "Up to 15 subjects will be enrolled.  Enrolled subjects will receive one Ulthera\u00ae treatment\n      on the face and neck.  Follow-up visits will occur at 45, 90 and 180 days post-treatment.\n      Study images will be obtained pre-treatment, immediately post-treatment, and at each\n      follow-up visit."
        }, 
        "brief_title": "Evaluation of the Ulthera\u00ae System for Treatment of the Face and Neck", 
        "completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Wrinkles", 
            "Rhytids", 
            "Skin Laxity"
        ], 
        "condition_browse": {
            "mesh_term": "Cutis Laxa"
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, single-center, pilot clinical trial to evaluate the efficacy of the\n      Ulthera\u00ae System to improve jawline definition and submental skin laxity. Changes from\n      baseline in the Fitzpatrick Facial Wrinkle Scale and facial pigmentation will be assessed at\n      study follow-up visits.  Global Aesthetic Improvement Scale scores, patient satisfaction\n      questionnaires, and quality of life questionnaires will be obtained."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, aged 30 to 65 years.\n\n          -  Subject in good health.\n\n          -  Score of 1 to 6 on the Fitzpatrick's Classification of Wrinkling Scale.\n\n          -  Mild to moderate rhytids in the periorbital or perioral region.\n\n          -  Mild to moderate laxity in the areas to be treated, which includes length and depth\n             of lines.\n\n          -  Mild to moderate vertical perioral lines\n\n          -  Mild to moderate marionette lines.\n\n          -  Subjects who desire lift and tightening of periorbital, perioral, and cheek tissue,\n             improvement in jawline definition and/or submental skin laxity\n\n          -  Understands and accepts the obligation not to undergo any other procedures in the\n             areas to be treated through the follow-up period.\n\n          -  Willingness and ability to comply with protocol requirements, including returning for\n             follow-up visits and abstaining from exclusionary procedures for the duration of the\n             study.\n\n        Exclusion Criteria:\n\n          -  Presence of an active systemic or local skin disease that may affect wound healing.\n\n          -  Severe solar elastosis.\n\n          -  Excessive subcutaneous fat on the cheek.\n\n          -  Excessive skin laxity on the lower face and neck.\n\n          -  Deep wrinkles, numerous lines, with or without redundant skin in the areas to be\n             treated.\n\n          -  Excessive hooding with or without redundant skin in the areas to be treated."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01713907", 
            "org_study_id": "ULT-109"
        }, 
        "intervention": {
            "arm_group_label": "Ulthera\u00ae treatment", 
            "description": "Focused ultrasound energy delivered below the surface of the skin.", 
            "intervention_name": "Ulthera\u00ae Treatment", 
            "intervention_type": "Device", 
            "other_name": [
                "Ultherapy\u2122 System", 
                "Ulthera, Inc."
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Ultherapy\u2122 treatment", 
            "Ulthera\u00ae System", 
            "Ulthera, Inc.", 
            "Ultrasound treatment for skin tightening"
        ], 
        "lastchanged_date": "February 27, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rockville", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20852"
                }, 
                "name": "Dermatology, Cosmetic & Laser Surgery"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of the Ulthera\u00ae System for Obtaining Lift and Tightening of the Facial Tissue and Improvement in Jawline Definition and Submental Skin Laxity", 
        "overall_official": {
            "affiliation": "Dermatology, Cosmetic & Laser Surgery", 
            "last_name": "Hema Sundaram, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Outcome measure determined based on a masked, qualitative assessment of standardized photographs at 90 days post-treatment compared to baseline", 
            "measure": "Improvement in facial wrinkles and lifting and tightening of skin", 
            "safety_issue": "No", 
            "time_frame": "90 days post-treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01713907"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Aesthetic improvement determined based on GAIS scores at follow-up, and the change in facial pigmentation and Fitzpatrick Facial Wrinkle Scale scores from baseline.", 
                "measure": "Overall aesthetic improvement", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed up to 180 days post-treatment"
            }, 
            {
                "description": "Determined based on Patient Satisfaction and Quality of Life questionnaire scores.", 
                "measure": "Overall patient satisfaction", 
                "safety_issue": "No", 
                "time_frame": "90 and 180 day post-treatment"
            }
        ], 
        "source": "Ulthera, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ulthera, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013", 
        "why_stopped": "Inadequate study staff to appropriately manage trial."
    }
}